The Biden administration announced Thursday that drug companies receiving research funding from HHS’ emergency response arm, the Administration for Strategic Preparedness and Response, will have to commit to a “fair price” – not more than they charge in other countries. Host Chelsea Cirruzzo talks with POLITICO health care reporter Robert King about the Biden administration's efforts to curb high prescription drug prices.
The latest on cannabis research from the office trying to study it
An AI decision maker in your emergency room?
Lawmakers say TikTok is killing kids
New report says CDC overstated vax data
The Sanders v. Moderna hearing
California and drugmaker partner to make affordable insulin
What GOP lawmakers are doing to keep abortion off the ballot
Tester wants to fix VA health records
New CDC report shows sharp rise in U.S. maternal deaths
Why the VA’s health arm will cover a new Alzheimer’s drug ... and Medicare won’t
How SVB's failure affects health tech
Daylight saving drama
A drug cost stat falls out of favor
Inside the President's budget
Next-gen Covid vaccine hopefuls part ways with K Street
Here's what drove Walgreens' abortion pill decision
The roadblock facing an opioid addiction treatment
Inside the FTC's deal with BetterHelp
GOP divided on how to respond to ‘lab leak’ reports
DeSantis and the 'medical freedom' movement
Create your
podcast in
minutes
It is Free